Rightslink® by Copyright Clearance Center

CLL-584 Genomic Alterations and Outcomes With Fixed-Duration Ibrutinib + Venetoclax: Results From the Phase 3 GLOW Study in Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Author:

Arnon Kater,Brendan Hodkinson,Carol Moreno,Talha Munir,Mark-David Levin,Carsten Niemann,Keqin Qi,Pierre Sinet,Kurt Baeten,Donne Bennett Caces,Srimathi Srinivasan

Publication:

Clinical Lymphoma Myeloma and Leukemia

Publisher:

Elsevier

Date:

September 2023

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.